Medication take-home doses and contingency management

  • Joy M. Schmitz
  • , Howard M. Rhoades
  • , Ronith Elk
  • , Daniel Creson
  • , Iman Hussein
  • , John Grabowski

Research output: Contribution to journalArticlepeer-review

Abstract

Two studies examined contingent take-home medication doses during treatment of opiate or cocaine dependence. In the first study, methadone maintenance patients were randomly assigned to one of two 8-week baseline take-home (TH) conditions differing in frequency of clinic visits per week. This was followed by a 12-week contingency management (CM) procedure in which frequent THs resulted from drug-free urines. Participants receiving more frequent THs during baseline had lower illicit drug use during the first 6 weeks of CM. In the second study, fluoxetine (0-, 20-, 40-mg) Th doses were similarly contingent in treatment of cocaine dependence. The 40-mg group used less cocaine during contingency than did other groups. The combination of fluoxetine and environmental contingencies may produce benefit where neither alone is sufficient.

Original languageEnglish (US)
Pages (from-to)162-168
Number of pages7
JournalExperimental and Clinical Psychopharmacology
Volume6
Issue number2
DOIs
StatePublished - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Medication take-home doses and contingency management'. Together they form a unique fingerprint.

Cite this